1 recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Refractory Lymphoblastic Lymphoma: new trials by email Literature Review of Refractory Lymphoblastic Lymphoma trials Research Report on Refractory Lymphoblastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Cyclophosphamide, Cytarabine, Dexamethasone - Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 4 | 2022-02-17 | 2025-08-11 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia Bortezomib, Clofarabine, Cyclophosphamide - Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 42 | 2017-08-09 | 2026-08-10 |
Burkitt Lymphoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
DNA Virus Infections (2) · Epstein-Barr Virus Infections (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Herpesviridae Infections (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, B-Cell (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2)
CT-P10 (2) · Calcium Dobesilate (2) · Cyclophosphamide (2) · Dexamethasone (2) · Rituximab (2) · Vincristine (2) · auricularum (2) · dexamethasone 21-phosphate (2) · dexamethasone acetate (2) · pegfilgrastim (2) · Bortezomib (1) · Clofarabine (1) · Cytarabine (1) · Etoposide (1) · Filgrastim (1)
M.D. Anderson Cancer Center (2)
United States (2)
Maro Ohanian (1) · Nicholas Short, MD (1)